x

75% of people globally want unbiased news (Pew Research) but are concerned they're not getting that.

Get balanced coverage with Symby. See how stories are covered across diverse outlets and spot when one side covers a story the other skips.

PODCAST

Listen to The Lancet Oncology

The Lancet Oncology

The Lancet Oncology is a monthly journal, renowned for the publication of high-quality peer reviewed research, reviews and analysis in cancer from around the world. In the monthly podcasts, editors of the journal discuss highlights of the current issue.

science & medicine

All Episodes

10:46

In conversation with... Gary Rodin

Listen to The Lancet Oncology ·

2025/11/02

Dr Gary Rodin discusses The human crisis in cancer: a Lancet Oncology Commission which identifies a growing imbalance between technological innovation and the human dimensions of cancer care.

en-uk

17:00

In conversation with... Matthias Preusser

Listen to The Lancet Oncology ·

2025/10/27

Deputy Editor Ali Landman speaks with Matthias Preusser about two reports from the phase 2 TUXEDO-3 trial investigating patritumab deruxtecan (HER3-Dxd) in patients with active brain metastases of breast cancer or non-small-cell lung cancer.

en-uk

12:15

In conversation with... Andrea Necchi

Listen to The Lancet Oncology ·

2025/09/29

Andrea Necchi, Associate Professor at the Vita-Salute San Raffaele University,discusses his SunRISe4-trial published in our October issue.

en-uk

14:22

In conversation with... Linda Bi, Ruchit Patel, Chloe...

Listen to The Lancet Oncology ·

2025/09/02

Kat Gourd, Acting Deputy Editor of The Lancet Oncology, is joined by Dr Linda Bi, Dr Ruchit Patel, Dr Chloe Gui, Dr Farshad Nassiri, and Dr Matija Snuderl, from institutions in the USA and Canada, to discuss two exciting papers on TERT expression and TERT promoter mutations in meningiomas.

en-uk

18:02

In conversation with... Richard Bryant

Listen to The Lancet Oncology ·

2025/04/30

Kat Gourd, Acting Deputy Editor of The Lancet Oncology, is joined by Professor Richard Bryant from the University of Oxford to discuss the TRANSLATE trialon transperineal vs transrectal biopsy for prostate cancer.

en-uk

07:33

In conversation with... Amar U. Kishan

Listen to The Lancet Oncology ·

2025/04/01

Professor Amar U. Kishan (Department of Radiation Oncology, University of California, Los Angeles, CA, USA) discusses his paper on HYpofractionateD RAdiotherapy for Prostate Cancer (HYDRA): An Individual Patient Data Meta-Analysis of Randomised Trials in the MARCAP Consortium.

en-uk

15:07

In conversation with... Steven Horwitz

Listen to The Lancet Oncology ·

2024/10/30

Dr Steven Horwitz (Memorial Sloan Kettering Cancer Center, New York, NY, USA) discusses a phase 1 study of valemetostat in relapsed or refractory non-Hodgkin lymphoma and a phase 2 study of valemetostat in relapsed or refractory peripheral T-cell lymphoma.

en-uk

40:45

In conversation with... May Abdel-Wahab and Andrew Scott

Listen to The Lancet Oncology ·

2024/09/30

May Abdel-Wahab (Division of Human Health, Department of Nuclear Science and Applications, International Atomic Energy Agency, Vienna, Austria) and Andrew Scott (Department of Molecular Imaging and Therapy, Austin Health, Melbourne, VIC, Australia) discuss The Lancet Oncology Commission on Radiotherapy and Theranostics.

en-uk

17:21

In conversation with... Zachary Zumsteg

Listen to The Lancet Oncology ·

2024/09/30

Dr Zachary Zumsteg (Cedars-Sinai Medical Center, Los Angeles, CA, USA) discusses his Review on the challenges and opportunities for early phase clinical trials of novel drug-radiotherapy combinations.

en-uk

24:08

In conversation with... Garth Strohbehn and Katie...

Listen to The Lancet Oncology ·

2024/05/29

Dr Garth Strohbehn (Veteran Affairs Center for Clinical Management Research, Ann Arbor, Michigan, USA) and Dr Katie Lichter (University of California, San Francisco, USA) discuss their papers on the environmental impact of cancer treatments and the public harms resulting from it.

en-uk

11:22

In conversation with... Bernardo Goulart

Listen to The Lancet Oncology ·

2024/04/09

Dr Bernardo Goulart (US Food and Drug Administration) discusses his paper on correlations of response rate and progression-free survival with overall survival in immunotherapy trials for metastatic non-small-cell lung cancer.

en-uk

25:42

In conversation with... Maria Kyrgiou

Listen to The Lancet Oncology ·

2024/03/08

In a special episode on International Women's Day 2024, we speak with Maria Kyrgiou (Imperial College London, London, UK) about her Essay on innovations and disparities in gynaecological cancer care.

en-uk

34:43

In conversation with... Georgios Lyratzopoulos

Listen to The Lancet Oncology ·

2024/02/27

Dr Georgios Lyratzopoulos (University College London, London, UK) discusses his two papers from the International Cancer Benchmarking Partnership on the use of chemotherapy or radiotherapy in eight common cancers in Norway, the UK, Canada, and Australia.

en-uk

13:53

In conversation with... Shankar Siva

Listen to The Lancet Oncology ·

2024/01/02

Senior Editor Owen Stretton talks to Professor Shankar Siva from the Peter MacCallum Cancer Centre in Melbourne about the International Society of Stereotactic Radiosurgery’s new systematic review and practice guidelines for stereotactic body radiotherapy in primary renal cell carcinoma.

en-uk

12:24

In conversation with... Neerja Bhatla

Listen to The Lancet Oncology ·

2023/11/28

Professor Neerja Bhatla (All India Institute of Medical Sciences, New Delhi, India) discusses her Article on the Immunogenicity and safety of a new quadrivalent HPV vaccine in girls and boys aged 9–14 years versus an established quadrivalent HPV vaccine in women aged 15–26 years in India.

en-uk

43:49

In conversation with... Chandra Are

Listen to The Lancet Oncology ·

2023/11/01

Dr Chandra Are (University of Nebraska Medical Center, Omaha, NE, USA) discusses highlights and recommendations from the Lancet Oncology Commission on Global Cancer Surgery: pragmatic solutions to improve cancer surgery outcomes worldwide.

en-uk

09:01

In conversation with... Ticiana Leal

Listen to The Lancet Oncology ·

2023/08/30

Ticiana Leal (Winship Cancer Institute at Emory University, Atlanta, GA, USA) discusses her paper on Tumour Treating Fields.

en-uk

33:50

In conversation with... Carlos Fernández de Larrea...

Listen to The Lancet Oncology ·

2023/07/03

Carlos Fernández de Larrea (Hospital Clínic de Barcelona, Barcelona, Spain) and Damian Green (Fred Hutch Cancer Center, Seattle, WA, USA) discuss their studies on BCMA CAR T cells in patients with relapsed or refractory multiple myeloma.

en-uk

14:01

In conversation with... Madeline Pe

Listen to The Lancet Oncology ·

2023/06/01

Madeline Pe (EORTC, Brussels, Belgium) discusses her Policy Review on the innovative medicines initiative, an expansion of the Setting International Standards in Analysing Patient-Reported Outcomes and Quality of Life Endpoints in Cancer Clinical Trials (SISAQOL) initiative.

en-uk

28:40

In conversation with... Kadia Petricca and Joyce Kambugu

Listen to The Lancet Oncology ·

2023/05/03

Dr Kadia Petricca (SickKids Hospital, Toronto, Canada), Dr Joyce Kambugu (Uganda Cancer Institute, Kampala, Uganda), and Dr Avi Denburg (SickKids Hospital) discuss their paper “Access to essential cancer medicines for children: a comparative mixed-methods analysis of availability, price, and health-system determinants in east Africa”.

en-uk

208 results

Similar Podcasts

科学史评话最新专辑

科学史评话

Hablando con Científicos - Cienciaes.com

cienciaes.com

天方烨谈

基因频道

The Permaculture Podcast

Scott Mann

汪诘：科学有故事（主打）

科学有故事